Drug Channels Archive for September, 2015

Click a link below to view the mailing archive as if it had been sent to you.

2015-09-29 07:33Drug Channels - Drug Channels News Roundup, September 2015: CVS Health, AmerisourceBergen, and Generic Inflation
2015-09-28 07:36Drug Channels - Real World Evidence & Market Access Summit 2015
2015-09-24 07:31Drug Channels - Why Walgreens Boots Alliance is Triggering a Huge AmerisourceBergen Stock Buyback
2015-09-22 07:29Drug Channels - New Cardinal and McKesson Customer Deals Show A Changing Generic Channel
2015-09-21 07:25Drug Channels - VA DoD PHS Federal Pricing and Contracts
2015-09-16 07:40Drug Channels - Here’s Who Will Pay For Prescription Drugs in 2024
2015-09-14 07:31Drug Channels - Customer Engagement Summit 2015
2015-09-10 07:27Drug Channels - A Roundup of 340B Omnibus Guidance Analyses
2015-09-09 07:48Drug Channels - Manufacturers: The Government Wants to Use 340B to Oversee and Publish Your Specialty Channel Strategy
2015-09-08 07:23Drug Channels - CBI’s Final Rule Forum
2015-09-04 06:26Drug Channels - Two Important Updates on #Zarxio and Biosimilar Reimbursement (rerun)
2015-09-03 06:40Drug Channels - CMS to Part D Preferred Pharmacy Networks: We’ll Be Watching You (rerun)
2015-09-02 06:58Drug Channels - Which PBM Best Managed Drug Trend in 2014: CVS Health, Catamaran, or Express Scripts? (rerun)
2015-09-01 07:50Drug Channels - Specialty Pharmacy’s Bright but Complex Future: Seven Reflections on #Armada15 (rerun)


<< Archive IndexSubscribe >>